Androgen Deprivation Therapy

Status: open

Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

Treatment for Prostate Cancer

Contact Us Or call (251) 445-9834

Description

RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens. Radiation therapy uses high-energy x-rays to kill tumor cells. PURPOSE: This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer.

Sponsors

This trial is sponsored by Radiation Therapy Oncology Group.

Providers Associated With This Trial

Principle Investigator

    Sub Investigators

    This link will open in a new tab or window.